CICC’s Subsidiary Leads $103M Series B In Tumor Radiotherapy Start-up Allcure Medical
July 24, 2018 — 11:42 CST
This Data Is Locked!
This area is available only to Subscribers.
China Capital Investment Group (CCIG), a subsidiary of CICC, has led a RMB700 million (US$102.67 million) series B round in Beijing Allcure Medical Technology Co.... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals
